ARS Pharmaceuticals, Inc.SPRYNASDAQ
Loading
Total Costs & Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+92.7%
5Y CAGR+70.5%
Studio
Year-over-Year Change

Total of all costs and expenses

3Y CAGR
+92.7%/yr
vs +19.1%/yr prior
5Y CAGR
+70.5%/yr
Recent acceleration
Acceleration
+73.7pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
14.4x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$263.73M+185.9%
2024$92.23M+36.5%
2023$67.55M+83.4%
2022$36.83M+47.6%
2021$24.96M+36.4%
2020$18.30M-23.9%
2019$24.07M+31.4%
2018$18.32M-